A novel treatment should train the immune system to target breast cancer. It's shown major promise in a 10-year-long clinical trial.
data from a Phase I safety trial of their vaccine, which involved 66 women with advanced stage breast cancer. The women had undergone treatment that either put their cancer into complete remission or largely contained it, but they remained at high risk of it aggressively reemerging. The volunteers were tracked for a median length of about 10 years.
In the trial, the vaccine showed no signs of serious long-term health risks, with the most common side effects being acute and short-lasting symptoms like redness at the injection site and fever. The volunteers also developed the immune responses that researchers hoped the vaccine would generate. And though Phase I trials are not meant to prove that a treatment works—only that it is safe—there was a clearly encouraging indicator of its effectiveness.
The HER2 vaccine developed by Disis and her colleagues is far from the only one being studied at the UW Cancer Vaccine Institute, but it is the furthest along in clinical trials. And in many ways, it’s the culmination of 30 years of work by Disis in particular.“I think the early challenge, years ago, was just that people didn’t think that the immune system played any role in cancer eradication,” she said.
“One of the other areas we’re working on is trying to increase the diversity of the patients that are represented in clinical trials—to make efforts to reach different parts of our community,” said Kiran Dhillon, executive director of the UW Cancer Vaccine Institute.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Alabama only state where Medicaid won’t cover some breast cancer screeningLifesaving tests for genes that increase risks of breast cancer still aren’t available to Alabama Medicaid recipients, despite a push by advocates who say the agency should offer the screening available in all other states.
Baca lebih lajut »
Fox Chase taking part in nationwide trial of vaccine to break Lynch Syndrome, genetic cancer chainOne in about 280 Americans carries genetic mutations raising their chance of colorectal, uterine, and other cancers. Fox Chase Cancer Center is helping test a new vaccine that could prevent some of those cancers.
Baca lebih lajut »
Rep. Joaquin Castro diagnosed with cancer, undergoes surgery at MD Anderson Cancer CenterU.S. Rep. Joaquin Castro underwent surgery in Houston Monday morning. If not for an accident on a dark road in Spain last summer, the tumors would have gone undetected.
Baca lebih lajut »
Austin experimental metal and rap festival announces full lineupOblivion Access will feature German prog rock legends Faust, British industrial band...
Baca lebih lajut »
Honda CR-V Hybrid Racer is 800bhp V6 track weapon | AutocarThis is the Honda CR-V Hybrid Racer - a one-off, V6 track demon which produces an eyewatering 800bhp 👀 What do you think?
Baca lebih lajut »
Sen. Bob Casey returns to work as Sen. John Fetterman continues treatmentCasey, who was recovering from surgery to treat prostate cancer, returned to the Senate Monday.
Baca lebih lajut »